ophthalmologytimes5 天
Atsena Therapeutics completes dosing in Part A of phase I/II clinical trial evaluating ATSN ...
In the LIGHTHOUSE study, Atsena Therapeutics is evaluating ATSN-201 gene therapy for X-linked retinoschisis, leveraging ...
Daily6 天
Vitamin D deficiency linked to higher foveal retinal thickness and decreased vascular ...
A new study published in the journal of Eye found that the amount of vitamin D and foveal retinal thickness (FRT) in children ...